NIVF logo

NewGenIvf Group Limited (NIVF)

Profile

Full Name

NewGenIvf Group Limited

Ticker Symbol

NIVF

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Care Facilities

Country

Hong Kong

IPO

March 18, 2022

Indexes

Not included

Website

http://newgenivf.com

Employees

70

Key Details

Price

$0.40(-1.95%)

Market cap

$682.80K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$5.14M(-13.59% YoY)

Annual EPS

$0.26(-71.61% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.40
NIVF price is $0.40

30-Day Relative Volume

0.04
NIVF 30-day relative volume is 0.04

Price Performance

Price Most recent change

-1.95%
NIVF price was down -1.95% on Apr 15, 2025

Price YTD change

-0.74%
NIVF price is down -0.74% since January 1st

Price 1-year change

-41.91%
NIVF price is down -41.91% year-on-year

Price 3-year change

-95.93%
NIVF price is down -95.93% over the past 3 years

Price Range

Price All-time high

$17.24
NIVF price is currently -97.67% below its historical high of $17.24

Price 3-year low

$0.11
NIVF price is currently +268.81% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$682.80K
NIVF market capitalization is $682.80 thousand

Market cap 3-year change

-
NIVF market capitalization 3-year change is unknown

Market cap All-time high

$4.38M
NIVF market capitalization is currently -84.42% below its historical high of $4.38 million

Market cap sector rank

3.37%
NIVF market capitalization is higher than 3.37% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+234.68%
NIVF shares outstanding is up +234.68% year-on-year

Shares Outstanding 3-Year Change

-
NIVF shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.22
NIVF beta is 1.22

200-day SMA

$0.80
NIVF price is currently -49.93% below its 200-day simple moving average

50-day SMA

$1.16
NIVF price is currently -65.29% below its 50-day simple moving average

RSI

31.44
NIVF 14-day relative strength index is 31.44

Volume

0.04
NIVF 30-day relative volume is 0.04

ATR

$0.13
NIVF average true range is $0.13

10-day Historical Volatility

124.72%
NIVF 10-day historical volatility is 124.72%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$5.14M
NIVF annual revenue is $5.14 million

Revenue Analysts estimate

-
NIVF annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-13.59%
NIVF annual revenue is down -13.59% year-on-year

Revenue Sector rank

-
NIVF annual revenue is unknown

EPS

EPS

$0.26
NIVF annual earnings per share is $0.26

EPS Analysts estimate

-
NIVF annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-71.61%
NIVF annual earnings per share is down -71.61% year-on-year

EPS Sector rank

-
NIVF annual earnings per share is unknown

Profit

Gross profit

$1.68M
NIVF annual gross profit is $1.68 million

Gross margin

32.74%
NIVF annual gross profit margin is 32.74%

Operating profit

$42.20K
NIVF annual operating income is $42.20 thousand

Operating margin

0.82%
NIVF annual operating profit margin is 0.82%

Net income

$130.20K
NIVF annual net profit is $130.20 thousand

Net margin

2.53%
NIVF annual net profit margin is 2.53%

Expenses

Total expenses

$5.09M
NIVF annual total expenses is $5.09 million

Operating expenses

$1.64M
NIVF annual total operating expenses is $1.64 million

Cost of goods sold

$3.45M
NIVF annual cost of goods sold is $3.45 million

Selling, general & administrative expenses

$1.64M
NIVF annual SGA is $1.64 million

Depreciation and amortization

$229.70K
NIVF annual depreciation & amortization is $229.70 thousand

Interest expense

$46.20K
NIVF annual interest expense is $46.20 thousand

Income tax

$0.00
NIVF annual income tax is $0.00

EBIT & EBITDA

EBIT

$154.60K
NIVF annual earnings before interest & taxes is $154.60 thousand

EBITDA

$384.30K
NIVF annual EBITDA is $384.30 thousand

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.65M
NIVF annual total assets is $1.65 million

Non current assets

$446.00K
NIVF annual long term assets is $446.00 thousand

Current assets

$1.20M
NIVF annual total current assets is $1.20 million

Cash and cash equivalents

$54.10K
NIVF annual cash & cash equivalents is $54.10 thousand

Accounts receivable

$9400.00
NIVF annual accounts receivable is $9400.00

Inventory

$126.30K
NIVF annual inventory is $126.30 thousand

Liabilities

Total liabilities

$1.24M
NIVF annual total liabilities is $1.24 million

Long term liabilities

$119.00K
NIVF annual total long term liabilities is $119.00 thousand

Current liabilities

$1.12M
NIVF annual total current liabilities is $1.12 million

Accounts payable

$172.60K
NIVF annual accounts payable is $172.60 thousand

Debt

Total debt

$332.60K
NIVF annual total debt is $332.60 thousand

Total debt 1-year change

-26.42%
NIVF annual total debt is down -26.42% year-on-year

Long term debt

$119.00K
NIVF annual long term debt is $119.00 thousand

Short term debt

$213.60K
NIVF annual short term debt is $213.60 thousand

Equity & Capital

Shareholders equity

$896.10K
NIVF annual stockholders equity is $896.10 thousand

Book value

$896.10K
NIVF annual book value is $896.10 thousand

Retained earnings

-$461.40K
NIVF annual retained earnings is -$461.40 thousand

Working capital

$79.00K
NIVF annual working capital is $79.00 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$1.77M
NIVF annual cash flow from operations is -$1.77 million

Cash from operations 1-year change

-203.23%
NIVF annual cash flow from operations is down -203.23% year-on-year

Cash from investing

-$69.80K
NIVF annual cash flow from investing activities is -$69.80 thousand

Cash from investing 1-year change

+26.14%
NIVF annual cash flow from investing activities is up +26.14% year-on-year

Cash from financing

$1.88M
NIVF annual cash flow from financing activities is $1.88 million

Cash from financing 1-year change

+215.16%
NIVF annual cash flow from financing activities is up +215.16% year-on-year

CAPEX

CAPEX

$69.80K
NIVF annual capital expenditures is $69.80 thousand

CAPEX 1-year change

-26.14%
NIVF annual capital expenditures is down -26.14% year-on-year

Free Cash Flow

Free cash flow

-$1.84M
NIVF annual free cash flow is -$1.84 million

Free cash flow 1-year change

-213.59%
NIVF annual free cash flow is down -213.59% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

32.74%
NIVF annual gross profit margin is 32.74%

Operating margin

0.82%
NIVF annual operating profit margin is 0.82%

Net margin

2.53%
NIVF annual net profit margin is 2.53%

ROA & ROE

ROA

5.72%
NIVF annual return on assets is 5.72%

ROE

51.39%
NIVF annual return on equity is 51.39%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NIVF price to earnings ratio value is unknown

PE ratio Sector rank

-
NIVF price to earnings ratio is unknown

PB Ratio

PB ratio

0.76
NIVF price to book ratio is 0.76

PB ratio Sector rank

37.86%
NIVF price to book ratio is higher than 37.86% of companies in Healthcare sector

PS Ratio

PS ratio

-
NIVF price to sales ratio value is unknown

PS ratio Sector rank

-
NIVF price to sales ratio is unknown

Enterprise value

Enterprise value

$961.30K
NIVF enterprise value is $961.30 thousand

Enterprise value Sector rank

13.73%
NIVF enterprise value is higher than 13.73% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
NIVF EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
NIVF EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.07
NIVF annual current ratio is 1.07

Quick ratio

0.96
NIVF annual quick ratio is 0.96

Leverage

Debt to equity

0.00
NIVF annual debt to equity ratio is 0.00

Interest coverage ratio

3.35
NIVF annual interest coverage ratio is 3.35

Risk & Stability

Piotroski F-Score

-
NIVF piotroski f-score value is unknown

Altman Z-Score

3.42
NIVF altman z-score is 3.42

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

SYRS logo
Syros Pharmaceuticals (SYRS)
LGMK logo
LogicMark (LGMK)
TNF Pharmaceuticals (TNFA)
SCPX logo
Scorpius Holdings (SCPX)
VIRX logo
Viracta Therapeutics (VIRX)
SRNE logo
Sorrento Therapeutics (SRNE)
ONCO logo
Onconetix (ONCO)
ATXI logo
Avenue Therapeutics (ATXI)
STSS logo
Sharps Technology (STSS)
  • What is the ticker symbol for NewGenIvf Group Limited?
  • Does NewGenIvf Group Limited pay dividends?
  • What sector is NewGenIvf Group Limited in?
  • What industry is NewGenIvf Group Limited in?
  • What country is NewGenIvf Group Limited based in?
  • When did NewGenIvf Group Limited go public?
  • Is NewGenIvf Group Limited in the S&P 500?
  • Is NewGenIvf Group Limited in the NASDAQ 100?
  • Is NewGenIvf Group Limited in the Dow Jones?
  • When does NewGenIvf Group Limited report earnings?

What is the ticker symbol for NewGenIvf Group Limited?

The ticker symbol for NewGenIvf Group Limited is NASDAQ:NIVF

Does NewGenIvf Group Limited pay dividends?

No, NewGenIvf Group Limited does not pay dividends

What sector is NewGenIvf Group Limited in?

NewGenIvf Group Limited is in the Healthcare sector

What industry is NewGenIvf Group Limited in?

NewGenIvf Group Limited is in the Medical Care Facilities industry

What country is NewGenIvf Group Limited based in?

NewGenIvf Group Limited is headquartered in Hong Kong

When did NewGenIvf Group Limited go public?

NewGenIvf Group Limited's initial public offering (IPO) was on March 18, 2022

Is NewGenIvf Group Limited in the S&P 500?

No, NewGenIvf Group Limited is not included in the S&P 500 index

Is NewGenIvf Group Limited in the NASDAQ 100?

No, NewGenIvf Group Limited is not included in the NASDAQ 100 index

Is NewGenIvf Group Limited in the Dow Jones?

No, NewGenIvf Group Limited is not included in the Dow Jones index

When does NewGenIvf Group Limited report earnings?

The date for NewGenIvf Group Limited's next earnings report has not been announced yet
On this page